Biocryst Pharmaceuticals, Inc. - BCRX - Stock Price Today ... View BioCryst Pharmaceuticals, Inc. BCRX investment & stock information. Get the latest BioCryst Pharmaceuticals, Inc. BCRX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. BCRX Stock Quote - BioCryst Pharmaceuticals, Inc. Common ... Stock quote for BioCryst Pharmaceuticals, Inc. Common Stock Common Stock (BCRX) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq.
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor, for the treatment of acute uncomplicated influenza under the RAPIVAB, ALPIVAB, RAPIACTA, and PERAMIFLU names; and Mundesine, an oral purine nucleoside phosphorylase inhibitor for peripheral T-cell lymphoma. BCRX -- Is Its Stock Price A Worthy Investment? Learn More.
View BioCryst Pharmaceuticals, Inc.'s fair value, stock price, financial statements, news, valuation models, fundamental charts, margin of safety, and more. Real time BioCryst Pharmaceuticals (BCRX) stock price quote, stock graph, news & analysis. 9 Mar 2020 investors would also find a great ally in the technical patterns of the stock movements showed in stock charts. BCRX showed a rise of 19.13% Stock analysis for BioCryst Pharmaceuticals Inc (BCRX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and View today's stock price, news and analysis for BioCryst Pharmaceuticals Inc. ( BCRX). Barron's also provides information on historical stock ratings, target prices The chart to the right plots the historical put/call ratio for this instrument. Using Put /Call Ratio as an indicator of investor sentiment overcomes one of the key 6 Oct 2014 I thought it would be interesting to analyze the charts since their discussion was primarily based on fundamentals. All of these stocks have had
BioCryst Pharmaceuticals, Inc. Common Stock (BCRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. BioCryst Pharmaceuticals Inc. advanced stock charts by MarketWatch. View BCRX historial stock data and compare to other stocks and exchanges. BioCryst Pharmaceuticals, Inc. BCRX 1.93 0.12 (5.88%). NASDAQUpdated Apr 7 , 2020 11:52 PM. 8,841. Watchers. Watch. Filter by: Real-Time BCRX: Get the latest BioCryst Pharmaceuticals stock price and detailed information including BCRX news, historical charts and realtime prices.
BCRX -- Is Its Stock Price A Worthy Investment? Learn More. BCRX Stock Summary. Of note is the ratio of Biocryst Pharmaceuticals Inc's sales and general administrative expense to its total operating expenses; just 12.98% of US stocks have a lower such ratio. BioCryst Pharmaceuticals Stock Forecast: down to 1.858 USD ... Historical index on US Stock Market : C "Should I invest in BioCryst Pharmaceuticals stock?" "Should I trade "BCRX" stock today?" According to our live Forecast System, BioCryst Pharmaceuticals, Inc stock is a bad long-term (1-year) investment*. "BCRX" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. BCRX Stock Quote - BioCryst Pharmaceuticals, Inc. Stock ...